Cargando…
Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119224/ https://www.ncbi.nlm.nih.gov/pubmed/34919203 http://dx.doi.org/10.1007/s12020-021-02956-y |
_version_ | 1784710659439591424 |
---|---|
author | Fulcher, Gregory R. Jarlov, Henrik Piltoft, Johanne Spanggaard Singh, Kiran Pal Liu, Lei Mohamed, Mafauzy Nicodemus, Nemencio Almare Al-Jaser, Saleh Jaser Kok, Adri |
author_facet | Fulcher, Gregory R. Jarlov, Henrik Piltoft, Johanne Spanggaard Singh, Kiran Pal Liu, Lei Mohamed, Mafauzy Nicodemus, Nemencio Almare Al-Jaser, Saleh Jaser Kok, Adri |
author_sort | Fulcher, Gregory R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9119224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-91192242022-05-20 Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design Fulcher, Gregory R. Jarlov, Henrik Piltoft, Johanne Spanggaard Singh, Kiran Pal Liu, Lei Mohamed, Mafauzy Nicodemus, Nemencio Almare Al-Jaser, Saleh Jaser Kok, Adri Endocrine Correction Springer US 2021-12-17 2022 /pmc/articles/PMC9119224/ /pubmed/34919203 http://dx.doi.org/10.1007/s12020-021-02956-y Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Correction Fulcher, Gregory R. Jarlov, Henrik Piltoft, Johanne Spanggaard Singh, Kiran Pal Liu, Lei Mohamed, Mafauzy Nicodemus, Nemencio Almare Al-Jaser, Saleh Jaser Kok, Adri Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
title | Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
title_full | Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
title_fullStr | Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
title_full_unstemmed | Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
title_short | Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
title_sort | correction: arise—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119224/ https://www.ncbi.nlm.nih.gov/pubmed/34919203 http://dx.doi.org/10.1007/s12020-021-02956-y |
work_keys_str_mv | AT fulchergregoryr correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT jarlovhenrik correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT piltoftjohannespanggaard correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT singhkiranpal correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT liulei correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT mohamedmafauzy correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT nicodemusnemencioalmare correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT aljasersalehjaser correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign AT kokadri correctionariseaprospectivenoninterventionalsinglearmstudyassessingclinicalparametersassociatedwiththeuseofinsulindegludecinsulinaspartinpatientswithtype2diabetesinrealworldsettingsrationaleanddesign |